Strides receives USFDA approval for Sevelamer Carbonate Tablets
10 May 2024 //
PRESS RELEASE
We are happy to share that the US DMF for Sevelamer Carbonate was successfully submitted to the USFDA
17 Feb 2023 //
PRESS RELEASE
Micro Labs` Generic Sevelamer Carbonate Receives Approval in the U.S.
07 Feb 2022 //
FDA
Lupin Receives Approval for Sevelamer Carbonate Tablets
25 Jan 2021 //
PRESS RELEASE
Impax Lab’s Generic Sevelamer Carbonate Receives Approval In US
25 Nov 2020 //
FDA
Zydus Pharms`s Generic Sevelamer Carbonate Receives Approval in US
14 Aug 2020 //
FDA
Mylan`s Generic Sevelamer Carbonate Receives Approval in US
08 Aug 2020 //
FDA
Anxin`s Generic Sevelamer Carbonate Receives Approval In US
14 Apr 2020 //
FDA
Dr.Reddy`s launches Sevelamer Carbonate in US
27 Dec 2018 //
INDIA INFOLINE
Wilshire Pharms`s Generic Sevelamer Carbonate Receives Approval in US
29 Nov 2018 //
FDA
Dr Reddys Labs `s Generic Sevelamer Carbonate Receives Approval in US
01 Nov 2018 //
FDA
Genzyme BV`s Generic Sevelamer carbonate Receives Marketing Approval in EU
09 Oct 2018 //
EMA
Invagen Pharm’s Generics Sevelamer Carbonate Receives Approval In US
30 Oct 2017 //
FDA
Cipla gets USFDA nod for generic version of Renvela tablets
26 Oct 2017 //
ECONOMIC TIMES
Impax Lab’s Generic Sevelamer Carbonate Receives Approval In US
26 Oct 2017 //
FDA
Impax Announces FDA Approval and Launch of Generic Renvela Sevelamer Carbonate
23 Oct 2017 //
PR NEWSWIRE
Aurobindo Pharma’s Generic Sevelamer Carbonate Receives Approval In US
15 Jun 2017 //
FDA
Aurobindo Pharma gets USFDA nod for oral suspension
15 Jun 2017 //
ECONOMIC TIMES
Sanofi adds its sales heft to Relypsa`s forthcoming patiromer launch
14 Aug 2015 //
FIERCE PHARMA MARKETING